Gentamicin is an antibiotic used to treat serious bacterial infections, including those affecting the blood, heart, lungs, and urinary tract. It works by killing bacteria that cause infections.[2] Garamycin is currently approved and in use across 35 indications[4].[1]
Garamycin is one of 466 small molecule programs targeting Catheter Infection. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
744 competitors in Breast Cancer
Garamycin
Adenocard
Zolymbus
Blenoxane
Voltaren
Lexiscan
MS Contin
Methylthioninium Chloride
Spravato
Duragesic-100
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Jan 1, 1982
GARAMYCIN
NDA NDA050505
Jan 1, 1982
GARAMYCIN
NDA NDA050425
Jan 1, 1982
GARAMYCIN
NDA NDA050039
Sources
Details